Enliven Therapeutics (ELVN) EBIT (2019 - 2026)
Enliven Therapeutics' EBIT was -$37.21 million in Q2 2026, compared with -$28.58 million a year earlier.
Powered by 
Analysis
Enliven Therapeutics (ELVN) EBIT (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enliven Therapeutics' EBIT was -$124.41 million through Jun 30, 2026; for FY2025, it came in at -$119.66 million.
- In earlier years, EBIT was -$104.55 million in FY2024, -$83.53 million in FY2023, -$38.79 million in FY2022 and -$51.44 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q1 2019.
- Per Business Quant data, ELVN's EBIT in the three quarters before Q2 2026 was -$27.82 million (Q1 2026), -$34.29 million (Q4 2025) and -$25.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Enliven Therapeutics | 3.37 Bn | 3.37 Bn | - | -37.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.21 Mn |
| Mar 31, 2026 | -27.82 Mn |
| Dec 31, 2025 | -34.29 Mn |
| Sep 30, 2025 | -25.10 Mn |
| Jun 30, 2025 | -28.58 Mn |
| Mar 31, 2025 | -31.69 Mn |
| Dec 31, 2024 | -26.90 Mn |
| Sep 30, 2024 | -27.07 Mn |
| Jun 30, 2024 | -24.60 Mn |
| Mar 31, 2024 | -25.99 Mn |
| Dec 31, 2023 | -22.73 Mn |
| Sep 30, 2023 | -24.25 Mn |
| Jun 30, 2023 | -20.13 Mn |
| Mar 31, 2023 | -16.42 Mn |
| Dec 31, 2022 | -10.16 Mn |
| Sep 30, 2022 | -10.93 Mn |
| Jun 30, 2022 | -9.02 Mn |
| Mar 31, 2022 | -8.68 Mn |
| Dec 31, 2021 | -14.33 Mn |
| Sep 30, 2021 | -13.66 Mn |
API Access
Enliven Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();